[email protected]
CDI - Contrive Datum Insights
Press ReleaseMedical Devices

Remote Patient Monitoring Market to Reach USD 70.8 billion by 2034 at 11.3% CAGR

Contrive Datum Insights has published "Remote Patient Monitoring Market Size, Share & Industry Analysis, By Product type (Vital Signs Monitors, Glucose Monitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Multi-parameter Monitors, Fetal and Neonatal Monitors, Neurological Monitors, Weight and Body Composition Scales), Component (Devices, Software and Platforms, Services), Application (Cardiovascular Diseases, Diabetes, Respiratory Diseases, Neurological Disorders, Cancer, Maternal and Fetal Health, Post-acute and Post-operative Care, Other Chronic Conditions), End user (Home Care Settings, Hospitals and Clinics, Ambulatory Care Centers, Assisted Living and Long-term Care Facilities, Rehabilitation Centers, Payers and Care Management Organizations), Connectivity technology (Bluetooth, Wi-Fi, Cellular, Wired and Hub-based, Other Wireless Protocols), Wearability (Wearable, Handheld, Tabletop and Bedside, Implantable and Ingestible), Deployment mode (Cloud-based, On-premise, Hybrid), Care model (Real-time Monitoring, Store-and-forward Monitoring, Hospital-at-home, Chronic Care Management, Principal Care Management), Patient age group (Geriatric, Adult, Pediatric, Neonatal), Sales channel (Direct to Providers, Distributors and Wholesalers, Retail and Pharmacies, Online and E-commerce, Payer-sponsored Programs), and Regional Forecast, 2026-2034". The study sizes the global remote patient monitoring market at USD 26 billion in 2025 and projects growth from USD 30 billion in 2026 to USD 70.8 billion by 2034, a compound annual growth rate of 11.3% across the forecast period.

PUNE, INDIA — 28 OCTOBER 2026 — CONTRIVE DATUM INSIGHTS

Market reaches USD 70.8 billion by 2034, up from USD 26 billion in 2025, at a 11.3% CAGR.

Fastest growth: Neurological Monitors at 16.34% a year.

Vital Signs Monitors leads product type with 24% of 2025 revenue.

Remote patient monitoring covers devices, software platforms and services that capture a patient's physiological data outside a clinical setting and send it to a care team for review and action. The category includes vital sign monitors, glucose and cardiac sensors, wearables and implantables, the cloud or on-premise software that collects and analyses the readings, and the enrolment and clinical support services around them. Buyers include hospitals and health systems, clinics, home care and assisted living operators, payers and care management organisations, and consumers who purchase connected devices directly.

Rising chronic disease burden and ageing populations

Rising chronic disease burden and ageing populations is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 11.3% a year, the product type lines exposed to it move fastest: Neurological Monitors compounds at 16.34%, taking its share of revenue from 4% to 6% and its value from USD 1.04 billion to USD 4.248 billion.

Where the forecast could be beaten: payers extend remote monitoring reimbursement to more conditions and countries, hospital-at-home programs scale quickly, and embedded cellular devices lift enrolment among older and rural patients. The study puts that case at USD 80.6 billion in 2034, against USD 70.8 billion in the base.

The downside is specific. Reimbursement rates are cut or tightened, alert fatigue and privacy compliance costs slow provider adoption, and device price erosion outpaces volume growth, and 2034 revenue lands at USD 59.4 billion. Vital Signs Monitors is the drag, 24% of the 2025 base compounding at 9.07% while the market runs at 11.3%.

The Competitive Split Runs by Product type

Two positions matter, and they are set by product type. Vital Signs Monitors carries 24% of 2025 revenue (USD 6.24 billion) and is still the largest line in 2034 at 20%, hard to take from an incumbent. Neurological Monitors, at 16.34%, is where the USD 26 billion base is redistributed. The two demand different capabilities.

Additional Findings

* * * Vital Signs Monitors was the leading product type line in 2025, taking 24% of revenue at USD 6.24 billion. * Neurological Monitors is projected to grow at 16.34% over the forecast period, the fastest of any product type line. * By component, Devices led in 2025 with 52% of revenue at USD 13.52 billion, while Software and Platforms grows fastest at 14.94%. * By application, Cardiovascular Diseases led in 2025 with 30% of revenue at USD 7.8 billion, while Neurological Disorders grows fastest at 16.03%. * By end user, Home Care Settings led in 2025 with 34% of revenue at USD 8.84 billion. * By connectivity technology, Bluetooth led in 2025 with 38% of revenue at USD 9.88 billion, while Cellular grows fastest at 16.52%. * By wearability, Tabletop and Bedside led in 2025 with 38% of revenue at USD 9.88 billion, while Wearable grows fastest at 15.8%. * By deployment mode, Cloud-based led in 2025 with 56% of revenue at USD 14.56 billion, while Hybrid grows fastest at 14.06%. * By care model, Chronic Care Management led in 2025 with 36% of revenue at USD 9.36 billion, while Hospital-at-home grows fastest at 17.77%. * By patient age group, Geriatric led in 2025 with 48% of revenue at USD 12.48 billion, while Neonatal grows fastest at 14.58%. * By sales channel, Direct to Providers led in 2025 with 38% of revenue at USD 9.88 billion, while Payer-sponsored Programs grows fastest at 15.8%. * The United States is the largest single country market at USD 9.4 billion in 2025, 36.15% of global revenue.

The report segments the market across ten axes; by product type, and by component, application, end user, connectivity technology, wearability, deployment mode, care model, patient age group and sales channel; with revenue and a growth rate for every line in every year from 2020 to 2034, alongside bear, base and bull scenarios for the headline total at USD 59.4 billion and USD 80.6 billion by 2034. It covers all five regions with country-level breakdowns, the competitive landscape, and the research methodology behind every estimate. Delivered as a PDF; a free sample is available on request.

Regions Covered
North AmericaEuropeAsia PacificLatin AmericaMiddle East and Africa
About Contrive Datum Insights

Contrive Datum Insights is a global market intelligence and consulting firm working across investment, information technology, healthcare and manufacturing markets. Every market we publish is sized twice — once top-down from the leading players and once bottom-up from the addressable base — and validated by primary interview. More about CDI.

Media contact
[email protected]
Asia Pacific
Kunjir Shyama Prestine, Sr. no. 174/1
Jagtap Diary Road, Pimple Saudagar
Pune 411017, India
+91 983 481 6757
United States
21C2 Lakeshore Dr.
Farmington, CT 06032
United States
+1 215 297 4078